Do the current medical and economic times dictate the need for the "polypill"?
作者信息
Rifai Luay, Khan Bobby V
机构信息
Grady Cardiovascular Research Center, Emory University School of Medicine, 69 Jesse Hill Drive SE, Atlanta, GA 30303, USA.
出版信息
J Clin Hypertens (Greenwich). 2009 Dec;11(12):775-6. doi: 10.1111/j.1751-7176.2009.00188.x.
Abstract
摘要
相似文献
1
Do the current medical and economic times dictate the need for the "polypill"?当前的医疗和经济形势是否表明需要“多效药丸”？
J Clin Hypertens (Greenwich). 2009 Dec;11(12):775-6. doi: 10.1111/j.1751-7176.2009.00188.x.
2
Benefits, challenges, and registerability of the polypill.多效药丸的益处、挑战及可注册性。
Eur Heart J. 2006 Jul;27(14):1651-6. doi: 10.1093/eurheartj/ehi841. Epub 2006 Apr 7.
3
Panacea in a pill?一粒药丸就能包治百病？
Prev Cardiol. 2004 Winter;7(1):46-7. doi: 10.1111/j.1520-037x.2004.02878.x.
4
Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.预防心血管疾病药物的依从性：对 376,162 名患者的荟萃分析。
Am J Med. 2012 Sep;125(9):882-7.e1. doi: 10.1016/j.amjmed.2011.12.013. Epub 2012 Jun 27.
5
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.一项基于复方药丸策略改善高危心血管疾病人群接受既定预防治疗的实用随机试验。
Eur J Prev Cardiol. 2015 Jul;22(7):920-30. doi: 10.1177/2047487314530382. Epub 2014 Mar 27.
6
Reflections on the regulation of the Polypill.关于复方药丸监管的思考。
Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):94-5. doi: 10.1038/ncpcardio1416. Epub 2008 Dec 2.
7
[Hypertension therapies compared. Are the new nevertheless better than the old?].[高血压治疗方法的比较。新疗法是否比旧疗法更好？]
MMW Fortschr Med. 2005 Mar 24;147(12):6, 8.
8
Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?多效药丸：其潜在的疗效增强能否引发新的关注？
Glob Heart. 2016 Dec;11(4):469-472. doi: 10.1016/j.gheart.2016.10.020.
9
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.检验多效药丸背后理论的必要性：印度多效复方制剂研究的理论依据
Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):96-7. doi: 10.1038/ncpcardio1438. Epub 2008 Dec 23.
10
The Polypill in the prevention of cardiovascular disease.用于预防心血管疾病的复方制剂
Prev Med. 2011 Jan;52(1):16-7. doi: 10.1016/j.ypmed.2010.11.015. Epub 2010 Dec 2.
本文引用的文献
1
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.代谢综合征的诊断与管理：美国心脏协会/美国国立心肺血液研究所科学声明
Circulation. 2005 Oct 25;112(17):2735-52. doi: 10.1161/CIRCULATIONAHA.105.169404. Epub 2005 Sep 12.
2
A strategy to reduce cardiovascular disease by more than 80%.一种将心血管疾病减少80%以上的策略。
BMJ. 2003 Jun 28;326(7404):1419. doi: 10.1136/bmj.326.7404.1419.
Zotero 插件